Homepage Latest Archives

Announcement

Thieme integrates Certara Chemaxon’s new generation chemical sketcher, Marvin, into its chemical databases Science of Synthesis and Pharmaceutical Substances

Latest version of Marvin is more accurate and user-friendly for Chemical Database Subscribers Stuttgart, Germany…

Danielle PillsburyApril 14, 2026

Announcement

Certara Near-Term Emissions Reduction Target Approved by Science Based Targets Initiative to Reduce Environmental Impact

Certara near-term emissions reduction target approved to advance ESG efforts and drive measurable climate action…

CertaraMarch 11, 2026

Press Release

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Novartis used PBPK modeling for therapeutic regulatory success. They used model simulations to replace clinical…

CertaraMarch 3, 2026

Press Release

Certara Automates Scientific Workflows with Phoenix® Cloud

Certara has released TFL studio, a module in its cloud-native PK/PD software, Phoenix Cloud, to…

CertaraNovember 4, 2025

Press Release

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Discover how Certara IQ accelerates drug development through scalable, QSP Modeling with AI-Powered Biosimulation.

CertaraOctober 30, 2025

Press Release

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Pinnacle 21® Enterprise Plus delivers a 50% reduction in time spent drafting mapping specifications, according…

CertaraSeptember 4, 2025

Press Release

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara announces that EMA has formally qualified the Simcyp® Simulator for use in regulatory submissions…

CertaraAugust 4, 2025

Press Coverage

The end of animal testing? Transitioning to models is promising — but no silver bullet

The FDA has stated that the pharma industry must transition to using in vitro assays,…

CertaraJuly 21, 2025

Press Release

Certara Announces Expansion of Clinical Technology Collaboration with Merck

July 8, 2025RADNOR, PA – July 8, 2025 – Certara, Inc. (Nasdaq: CERT), a global…

CertaraJuly 8, 2025

Press Coverage

Increasing Productivity In Pharma R&D Starts With Data

This article discusses the growing volume of raw data collected during clinical research, and how…

CertaraJune 25, 2025

Homepage Latest

Thieme integrates Certara Chemaxon’s new generation chemical sketcher, Marvin, into its chemical databases Science of Synthesis and Pharmaceutical Substances

Certara Near-Term Emissions Reduction Target Approved by Science Based Targets Initiative to Reduce Environmental Impact

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Certara Automates Scientific Workflows with Phoenix® Cloud

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

The end of animal testing? Transitioning to models is promising — but no silver bullet

Certara Announces Expansion of Clinical Technology Collaboration with Merck

Increasing Productivity In Pharma R&D Starts With Data

Newsletter sign up

Quick links

Solutions

Contact